11
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Role of FGF3 in Otic Capsule Chondrogenesis in vitro: An Antisense Oligonucleotide Approach

&
Pages 173-182 | Received 17 Mar 1997, Accepted 01 Aug 1997, Published online: 21 Aug 2009

References

  • Acland P., Dixon M., Peters G., Dickson C. Subcellular fate of the Int-2 oncoprotein is determined by choice of initiation codon. Nature 1990; 343: 662–665
  • Akhtar S., Juliano R. L. Cellular uptake and intracellular fate of antisense oligonucleotides. Trends in Cell Biol. 1992; 2: 39–44
  • Cornell R. A., Musci T. J., Kimelman D. FGF is a prospective competence factor for early activin-type signals in Xenopus mesoderm induction. Development 1995; 121: 2429–2437
  • Dash P., Lotan I., Knapp M., Kandel E. R., Goelet P. Selective elimination of mRNAs in vivo: Complimentary oligodeoxynucleotides promote RNA degradation by an RNase H-loke activity. Proc. Natl. Acad. Sci. USA 1987; 84: 7896–7900
  • Florini J. R., Magri K. A., Ewton D. Z., James P. L., Grind-Staff K., Rotwein P. S. “Spontaneous” differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor II. J. Biol. Chem. 1991; 266: 15917–15923
  • Frenz D. A., Van De Water T. R. Epithelial control of periotic mesenchyme chondrogenesis. Dev. Biol. 1991; 144: 38–46
  • Frenz D. A., Galinovic-Schwartz V., Flanders K. C., Van De Water T. R. TGF-β1 is an epithelial-derived signal peptide that influences otic capsule formation. Dev. Biol. 1992; 153: 324–336
  • Frenz D. A., Liu W., Williams J. D., Hatcher V., Galinovic-Schwartz V., Flanders K. C., Van De Water T. R. Induction of chondrogenesis: requirement for synergistic interaction of basic fibroblast growth factor and transforming growth factor-beta. Development 1994; 120: 415–424
  • Frenz D. A., Liu W., Capparelli M. The role of BMP-2a in otic capsule chondrogenesis. Ann. N.Y. Acad. Sci., 785: 256–258
  • Hansen J. N., Konkel D. A., Leder P. The sequence of a mouse embryonic beta-globin gene. Evolution of the gene and its signal region. J. Biol. Chem. 1982; 257: 1048–1052
  • Kengaku M., Okamoto H. Basic fibroblast growth factor induces differentiation of neural tube and neural crest lineages of cultured ectoderm cells from Xenopus gastrula. Development 1993; 119: 1067–1078
  • Kronmiller J. E., Upholt W. B., Kollar E. J. EGF antisense oligodeoxynucleotides block murine odontogenesis in vitro. Dev. Biol. 1991; 147: 485–488
  • Kurokawa M., Doctrow S. R., Klagsbrun M. Neutralizing antibodies inhibit the binding of basic fibroblast growth factor to its receptor but not to heparin. J. Biol. Chem. 1989; 264: 7686–7691
  • Loke S. L., Stein C. A., Zhang X. H., Mori K., Nakanishi M., Subasinghe C., Cohen S. J., Neckers L. M. Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. USA 1989; 86: 3474–3478
  • Mahmood R., Mason J. J., Morriss-Kay G. M. Expression of FGF-3 in relation to hindbrain segmentation, otic pit position and pharyngeal arch morphology in normal and retinoic acid-exposed mouse embryos. Anat. and Embryol. 1996; 194: 13–22
  • Mansour S. L., Martin G. R. Four classes of mRNA are expressed from the mouse int-2 gene, a member of the FGF family. EMBO J. 1988; 7: 2035–2041
  • Mansour S. L., Goddard J. M., Capecchi M. Mice homozygous for a targeted disruption of the proto-oncogene int-2 have developmental defects in the tail and inner ear. Development 1993; 117: 13–28
  • Mathieu M., Chatelain E., Ornitz D., Bresnick J., Mason I., Kiefer P., Dickson C. Receptor binding and mito-genic properties of mouse fibroblast growth factor 3. J. Biol. Chem. 1995; 270: 24197–24203
  • McKay I. J., Lewis J., Lumsden A. The role of FGF-3 in early inner ear development: an analysis in normal and kreisler mutant mice. Devel. Biol. 1996; 174: 370–378
  • Moore R., Casey G., Brookes S., Dixon M., Peters G., Dickson C. Sequence, topography and protein coding potential of mouse int-2: a putative oncogene activated by mouse mammary tumour virus. EMBO J. 1986; 5: 919–924
  • Munroe S. H. Antisense RNA inhibits splicing of pre-mRNA in vitro. EMBO J. 1988; 7: 2523–2532
  • Parker P. J., Young S., Gullick W. J., Mayes E. L., Bennett P., Waterfield M. D. Monoclonal antibodies against the human epidermal growth factor receptor from A431 cells. Isolation, characterization, and use in the purification of active epidermal growth factor receptor. J. Biol. Chem. 1984; 259: 9906–9912
  • Paterno G. D., Gillepsie L. L., Dixon M. S., Slack J. M., Heath J. K. Mesoderm-inducing properties of INT-2 and kFGF: two oncogene-encoded growth factors related to FGF. Development 1989; 106: 79–83
  • Potts J. D., Dagle J. M., Weeks D. L., Runyan R. B. Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor β3. Proc. Natl. Acad. Sci. USA 1991; 88: 1516–1520
  • Represa J., Leon Y., Miner C., Giraldez F. The int-2 proto-oncogene is responsible for induction of the inner ear. Nature 1991; 353: 561–563
  • Sariola H., Saarma M., Sainio K., Arumae U., Palgi J., Vaah-Tokari A., Thesleff I., Karavanov A. Dependence of kidney morphogenesis on the expression of nerve growth factor receptor. Science 1991; 254: 571–573
  • Van De Water T. R., Represa J. Tissue interactions and growth factors that control development of the inner ear. Ann. N.Y. Acad. Sci. 1991; 630: 116–128
  • Walder R. Y., Walder J. A. Role of RNAse H in hybrid-arrested translation by antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 1988; 85: 5011–5015
  • Wilkinson D. G., Peters G., Dickson C., McMahon A. P. Expression of the FGF-related proto-oncogene int-2 during gastrulation and neurulation in the mouse. EMBO J. 1988; 7: 691–695
  • Wilkinson D. G., Bhatt S., McMahon A. P. Expression pattern of the FGF-related proto-oncogene int-2 suggests multiple roles in fetal development. Development 1989; 105: 131–136
  • Yeaton R. W., Lipari M. T., Fox C. F. Calcium-mediated degradation of epidermal growth factor receptor in dislodged A431 cells and membrane preparations. J. Biol. Chem. 1983; 258: 9254–9261

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.